TELLURIAN INC (TELL)

US87968A1043 - Common Stock

0.4441  +0.02 (+4.3%)

After market: 0.441 0 (-0.7%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to TELL. TELL was compared to 214 industry peers in the Oil, Gas & Consumable Fuels industry. TELL may be in some trouble as it scores bad on both profitability and health. TELL is quite expensive at the moment. It does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

TELL had negative earnings in the past year.
In the past year TELL has reported a negative cash flow from operations.
TELL had negative earnings in each of the past 5 years.
In the past 5 years TELL always reported negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -12.55%, TELL is not doing good in the industry: 92.06% of the companies in the same industry are doing better.
TELL has a worse Return On Equity (-26.59%) than 88.32% of its industry peers.
Industry RankSector Rank
ROA -12.55%
ROE -26.59%
ROIC N/A
ROA(3y)-11.5%
ROA(5y)-29.22%
ROE(3y)-20.48%
ROE(5y)-69.16%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

TELL's Gross Margin of 52.54% is in line compared to the rest of the industry. TELL outperforms 54.67% of its industry peers.
In the last couple of years the Gross Margin of TELL has grown nicely.
TELL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.24%
GM growth 5Y5.33%

1

2. Health

2.1 Basic Checks

TELL does not have a ROIC to compare to the WACC, probably because it is not profitable.
TELL has more shares outstanding than it did 1 year ago.
TELL has more shares outstanding than it did 5 years ago.
TELL has a better debt/assets ratio than last year.

2.2 Solvency

TELL has an Altman-Z score of -1.21. This is a bad value and indicates that TELL is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of TELL (-1.21) is worse than 75.70% of its industry peers.
TELL has a Debt/Equity ratio of 0.77. This is a neutral value indicating TELL is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.77, TELL is not doing good in the industry: 64.49% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF N/A
Altman-Z -1.21
ROIC/WACCN/A
WACC5.33%

2.3 Liquidity

TELL has a Current Ratio of 0.66. This is a bad value and indicates that TELL is not financially healthy enough and could expect problems in meeting its short term obligations.
TELL has a worse Current ratio (0.66) than 81.31% of its industry peers.
A Quick Ratio of 0.66 indicates that TELL may have some problems paying its short term obligations.
TELL has a Quick ratio of 0.66. This is in the lower half of the industry: TELL underperforms 76.64% of its industry peers.
Industry RankSector Rank
Current Ratio 0.66
Quick Ratio 0.66

5

3. Growth

3.1 Past

TELL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -172.73%.
TELL shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -57.61%.
TELL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 74.42% yearly.
EPS 1Y (TTM)-172.73%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-133.33%
Revenue 1Y (TTM)-57.61%
Revenue growth 3Y64.34%
Revenue growth 5Y74.42%
Revenue growth Q2Q-61.03%

3.2 Future

TELL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.27% yearly.
TELL is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 46.96% yearly.
EPS Next Y26.9%
EPS Next 2Y24.14%
EPS Next 3Y19.21%
EPS Next 5Y9.27%
Revenue Next Year-48.79%
Revenue Next 2Y-38.08%
Revenue Next 3Y-25.99%
Revenue Next 5Y46.96%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

0

4. Valuation

4.1 Price/Earnings Ratio

TELL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TELL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as TELL's earnings are expected to grow with 19.21% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.14%
EPS Next 3Y19.21%

0

5. Dividend

5.1 Amount

TELL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

TELLURIAN INC

NYSEARCA:TELL (5/7/2024, 3:13:34 PM)

After market: 0.441 0 (-0.7%)

0.4441

+0.02 (+4.3%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap370.03M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.55%
ROE -26.59%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 52.54%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.66
Quick Ratio 0.66
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-172.73%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y26.9%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-57.61%
Revenue growth 3Y64.34%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y